SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sun Pharma Advanced Research Company informs about disclosure

03 Jun 2021 Evaluate
In compliance with Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) (Amendments) Regulations, 2018, Sun Pharma Advanced Research Company has informed that it submitted the Related Party Transactions on consolidated basis, in accordance with the applicable accounting standards, for the half year ended 31st March 2021.

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Adv. Res Share Price

146.70 -1.20 (-0.81%)
20-Apr-2026 11:11 View Price Chart
Peers
Company Name CMP
Syngene Internation. 437.95
Indegene 486.70
CMS Info Systems 317.95
JITF Infralogistics 331.25
Sagility 42.36
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×